Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-05-28
2009-11-24
Canella, Karen A (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C435S325000, C435S252300, C435S254110
Reexamination Certificate
active
07622564
ABSTRACT:
PSCA and its encoded protein, and variants thereof, are described wherein PSCA exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, PSCA provides a diagnostic, prognostic, propylactic and/or therapeutic target for cancer. The PSCA gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with PSCA can be used in active or passive immunization.
REFERENCES:
patent: 6258939 (2001-07-01), Reiter et al.
patent: 6635468 (2003-10-01), Ashkenazi et al.
patent: 6824780 (2004-11-01), Devaux et al.
patent: 6979730 (2005-12-01), Reiter et al.
patent: 2003/0023054 (2003-01-01), Ashkenazi et al.
patent: 2004/0018571 (2004-01-01), Reiter et al.
patent: 1 514 876 (2005-03-01), None
patent: WO 98/00540 (1998-01-01), None
patent: WO-98/40403 (1998-09-01), None
patent: WO-98/51805 (1998-11-01), None
patent: WO 98/51805 (1998-11-01), None
patent: WO 98/51824 (1998-11-01), None
patent: WO-01/40309 (2001-06-01), None
patent: WO-03/074654 (2003-09-01), None
Strausberg, R. (Accession No. BI763933, GI: 1575511 Sep. 25, 2001).
Arlen et al., Critical Review in Immunology (1998) 18:133-138.
Arthur et al., Cancer Gene Therapy (1997) 4:17-25.
Ashley et al., Journal of Experimental Medicine (1997) 186:1177-1182.
Bamezai and Rock, Nat'l. Acad. Sci USA (1995) 92:4294-4298.
Brakenhoff et al., Journal of Cell Biology (1995) 129:1677-1689.
Braun et al., Molecular and Cell Biology (1995) 15:4623-4630.
Cher et al., Genes Chromosomes and Cancer (1994) 11:153-162.
Cohen et al., Proc. Nat'l. Acad. Sci. USA (1972) 69:2110-2114.
Cupp and Oesterling, Mayo Clinic Proceedings, (1993) 68:297-306.
Deleersnijder et al., Journal of Biological Chemistry (1996) 271:19475-19482.
Fields and Song, Nature (1989) 340:245-246.
Fong et al., Journal of Immunology (1997) 159:3113-3117.
Foon et al., Journal of Clinical Investigation (1995) 96:334-342.
Fritz and Lowe, American Journal of Physiology (1996) 270:G176-G183.
Funakoshi et al., Journal of Immunotherapy (1996) 19(2):93-101.
Graham and Van Der Eb, Virology (1973) 52:456-467.
Liu et al., Cancer Research (1998) 58:4055-4060.
Henderson et al., Cancer Research (1996) 56:3763-3770.
Herlyn et al., Cancer Immunology Immunotherapy (1996) 43:65-76.
Hodge et al., International Journal of Cancer (1995) 63:231-237.
Israeli et al., Cancer Research (1993) 53:227-230.
Jenkins et al., Cancer Research (1997) 57:524-531.
Kasprzyk et al., Cancer Research (1992) 52:2771-2776.
Katz et al., International Journal of Cancer (1994) 59:684-691.
Kieffer et al., Biochemistry (1994) 33:4471-4482.
Klein et al., Nature Medicine (1997) 3:402-408.
Lalani et al., Cancer and Metastasis Reviews (1997) 16:29-66.
Lee and Oesterling, “Cancer of the Prostate: Diagnosis and Staging,” in Urologic Oncology, Oesterling and Richie (eds.), (1997) pp. 357-377.
Magi-Galluzzi et al., Laboratory Investigation (1997) 76:37-51.
Mao et al., Proc. Nat 'l. Acad. Sci. USA (1996) 93:5910-5914.
Mount et al., Cancer Research (1994) 54:6160-6166.
Noda et al., Journal of Experimental Medicine (1996) 183:2355-2360.
Ozaki et al., Blood (1997) 90:3179-3186.
Qian et al., Cancer Research (1995) 55:5408-5414.
Restifo, Current Opinion in Immunology (1996) 8:658-663.
Ribas et al., Cancer Research (1997) 57:2865-2869.
Rowley et al., Proc. Nat'l. Acad. Sci. USA (1990) 87:9358-9362.
Shepard et al., Journal of Clinical Immunology (1991) 2:117-127.
Southern and Berg, Journal of Molecular and Applied Genetics (1982) 1:327-341.
Southern, Journal of Molecular Biology (1975) 98:503-517.
Thomas and Samelson, The Journal of Biological Chemistry (1992) 267:12317-12322.
Thorpe and Ross, Immunological Review (1982) 62:119-158.
Towbin et al., Proc. Nat'l. Acad. Sci. USA (1979) 76:4350-4354.
Tsunenari et al., Blood (1997) 90:2437-2444.
Udenfriend and Kodukula, Annual Review of Biochemistry (1995) 64:563-591.
Veis et al., Cell (1993) 75:229-240.
Velders et al., Cancer Research (1995) 55:4398-4403.
Wagner et al., Hybridoma (1997) 16:33-40.
Wigler et al., Proc. Nat'l. Acad. Sci. USA (1979) 76:1373-1376.
Yang et al., American Journal of Pathology (1997) 150:693-704.
Zhong et al., Leukemia Research (1996) 20:581-589.
Boulianne et al., Nature (1984) 312:643-646.
Fell et al., Proc. Nat'l. Acad. Sci. USA (1989) 86:8507-8511.
Hellstrom et al., Proc. Nat'l. Acad. Sci. USA (1985) 82:1499-1502.
Hellstrom et al., “Antibodies for Drug Delivery,” in Controlled Drug Delivery, 2nded., Robinson et al. (eds.), (1987) pp. 623-653.
Neuberger et al., Nature (1984) 312:604-608.
Sahagan et al., The Journal of Immunology (1986) 137:1066-1074.
Sharon et al., Nature (1984) 309:364-367.
Shizuya et al., Proc. Nat'l. Acad. Sci. USA (1992) 89:8794-8797.
Tan et al., The Journal of Immunology (1985) 135:3564-3567.
Vitetta et al., “Immunotoxin Therapy,” in Cancer: Principles and Practice of Oncology, 4th edition, De Vita Jr., et al ., (eds,), (1993) pp. 2624-2636.
Algate et al., Blood (1994) 83(9):2459-2468.
Arnon et al., “Monoclonal Antibodies for Immunotargeting of Drugs in Cancer Therapy,” in Monoclonal Antibodies and Cancer Therapy, Reisfeld and Sell (eds.), (1985) pp. 243-256.
Bacchetti and Graham, Proc. Nat'l. Acad. Sci. USA (1977) 74(4):1590-1594.
Berent et al., BioTechniques (1985) 3:208-219.
Berkner, BioTechniques (1988) 6(7):616-626.
Bonkhoff and Remberger, The Prostate (1996) 28(2):98-106.
Bonkhoff et al., The Prostate (1994) 24:114-118.
Boshart et al., Cell (1985) 41(2):521-530.
Breviario et al., The Journal of Biological Chemistry (1992) 267(31):22190-22197.
Brinster et al., Cell (1984) 37:367-379.
Brinster et al., Proc. Nat'l. Acad. Sci. USA (1988) 85:836-840.
Cluitmans et al., Annals of Hematology (1994) 68:293-298.
De Wit et al., British Journal of Hematology (1994) 86:259-264.
DePamphilis et al., BioTechniques (1988) 6(7):662-680.
Espinoza-Delgado et al., the Journal of Immunology (1992) 149(9):2961-2968.
Felgner et al., Proc. Nat'l. Acad. Sci. USA (1987) 84:7413-7417.
Felgner et al., Proceedings of the Western Pharmacology Society (1989) 32:115-121.
Freireich et al., Cancer Chemotherapy Reports (1966) 50(4):219-244.
Gao et al., The Prostate (1997) 31:264-281.
Garabedian et al., Proc. Nat'l. Acad. Sci. USA (1998) 95:15382-15387.
Geller et al., Proc. Nat'l. Acad. Sci. USA (1990) 87:8950-8954.
Ghosh-Choudhury et al., Gene (1986) 50:161-171.
Greenberg et al., Proc. Nat'l. Acad. Sci. USA (1995) 92:3439-3443.
Hock and Miller, Nature (1986) 320:275-277.
Horisberger et al., Journal of Virology (1990) 64(3):1171-1181.
Kaufman, Proc. Nat'l. Acad. Sci. USA (1985) 82:689-693.
Kaufman, Methods in Enzymology (1990) 185:487-511.
Kay et al., Journal of Experimental Medicine (1991) 173:775-778.
Lagoo et al., The Journal of Immunology (1994) 152(4):1641-1652.
Li and Stashenko, The Journal of Immunology (1992) 148(3):788-794.
Martinez et al., Transplantation (1993) 55(5):1159-1166.
Mauviel et al., The Journal of Immunology (1992) 149(9):2969-2976.
Maxam and Gilbert, Methods in Enzymology (1980) 65:499-560.
Maroulakou et al., Proc. Nat'l. Acad. Sci. USA (1994) 91:11236-11240.
Murphy et al., The Prostate (1996) 29:371-380.
Pang et al., Clinical and Experimental Immunology (1994) 96:437-443.
Panicali and Paoletti, Proc. Nat'l. Acad. Sci. USA (1982) 79:4927-4931.
Pizarro et al., Transplantation (1993) 56(2):399-404.
Rosenfeld et al., Science (1991) 252:431-434.
Sarver et al., Molecular and Cellular Biology (1981) 1(6):486-496.
Schaefer-Ridder et al., Science (1982) 215:166-168.
Shimane et al., Biochemical and Biophysical Research Communications (1994) 199:26-32.
Smith et al., Nature (1993) 302:490-495.
Sprecher and Becker, Archives of Virology (1992) 126:253-269.
Stavridis et al., Experimental Cell Research (1986) 164:568-572.
Tjoa et al., The Prostate (1996) 28:65-69.
Ulich et al., The Journal of Immunology (1991) 146(7):2316-2323.
Wong et al., Science (1985) 228:810-815.
Bzdega et al., Journal of Neurochemistry (1997) 69(6):2270-2277.
Ca
Challita-Eid Pia M.
Ge Wangmao
Jakobovits Aya
Raitano Arthur B.
Agensys, Inc.
Canella Karen A
Morrison & Foerster / LLP
Reddig Peter J
LandOfFree
Prostate stem cell antigen (PSCA) variants and subsequences... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate stem cell antigen (PSCA) variants and subsequences..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate stem cell antigen (PSCA) variants and subsequences... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112571